Economic burden of antibiotic resistance in China: a national level estimate for inpatients
Abstract Background Antibiotic resistance (AR) threats public health in China. National-level estimation of economic burden of AR is lacking. We aimed to quantify the economic costs of AR in inpatients in China. Methods We performed a multicentre and retrospective cohort study including 15,990 patie...
Main Authors: | Xuemei Zhen, Cecilia Stålsby Lundborg, Xueshan Sun, Nina Zhu, Shuyan Gu, Hengjin Dong |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-01-01
|
Series: | Antimicrobial Resistance and Infection Control |
Subjects: | |
Online Access: | https://doi.org/10.1186/s13756-020-00872-w |
Similar Items
-
Economic burden of antibiotic resistance in ESKAPE organisms: a systematic review
by: Xuemei Zhen, et al.
Published: (2019-08-01) -
Clinical and Economic Burden of Carbapenem-Resistant Infection or Colonization Caused by <i>Klebsiella pneumoniae</i>, <i>Pseudomonas aeruginosa</i>, <i>Acinetobacter baumannii</i>: A Multicenter Study in China
by: Xuemei Zhen, et al.
Published: (2020-08-01) -
The Clinical and Economic Impact of Antibiotic Resistance in China: A Systematic Review and Meta-Analysis
by: Xuemei Zhen, et al.
Published: (2019-08-01) -
Correction to: Economic burden of antibiotic resistance in China: a national level estimate for inpatients
by: Xuemei Zhen, et al.
Published: (2021-04-01) -
Global disease burden due to antibiotic resistance – state of the evidence
by: Mark Woolhouse, et al.
Published: (2016-06-01)